American Regent, Inc. has issued a voluntary nationwide recall of three lots of Epinephrine Injection due to the presence of particulate matter and lack of assurance of sterility, which may pose serious health risks.

US · 2026-09-04

1. Step 1 · The triggerAmerican Regent recalls three lots of Epinephrine Injection due to contamination risks
2. Step 2 · Knock-onReduced availability of Epinephrine Injection impacts healthcare providers relying on this product
3. Step 3 · Reaches youHealthcare providers seek alternative suppliers to ensure continuity of care

The trigger is reported by the source below. The steps that follow are Branch²’s traced reasoning — how the shock could reach a business like yours, not a prediction.

Source: fda.gov

This is automated analysis for information only. It is not investment advice, not a recommendation, and not a solicitation to buy or sell any security. Branch² is not authorised or regulated. Do your own research.